For information on our TSX listing, please visit https://web.tmxmoney.com/quote.php?locale=en&qm_symbol=ONC
For information on our OTCQX listing, please visit https://www.otcmarkets.com/stock/ONCYF/quote
Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas
Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer
Oncolytics Biotech® to Present at the Oncolytic Virotherapy Summit
View All NewsOncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More
Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More
Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More
Due to unexpected COVID-19 issues, Oncolytics will not be able to participate in the RBC Conference on Wednesday. W… https://t.co/qnLGkbf6Wp
CEO Matt Coffey will be at the 2022 @RBC Capital Markets Global Healthcare Conference participating in a fireside c… https://t.co/8fVv0S6Gbk